Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo.
Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo.
复制标题
DOI:
10.4161/cc.8.14.9101
复制
发表时间:
2009-07-15
期刊:
影响因子:
--
通讯作者:
Cance WG
中科院分区:
文献类型:
--
作者:
Kurenova EV;Hunt DL;He D;Fu AD;Massoll NA;Golubovskaya VM;Garces CA;Cance WG
Vascular endothelial growth factor receptor-3 is a receptor tyrosine kinase that is overexpressed in some human carcinomas, but its role in tumorigenesis has not been fully elucidated. We examined VEGFR-3 expression in normal, nonneoplastic and early stage malignant breast tissues and have shown that VEGFR-3 upregulation in breast cancer preceded tumor cell invasion, suggesting that VEGFR-3 may function as a survival signal. We characterized the biological effects of VEGFR-3 over-expression in human breast cancer cells based on two approaches: gain of function by overexpressing VEGFR-3 in MCF-7 breast cancer cells and loss of function by RNAi-mediated silencing of VEGFR-3 in MCF-7-VEGFR-3 and BT474 cells. VEGFR-3 overexpression increased cellular proliferation by 40% when MCF7-VEGFR-3 cells were compared to parental MCF7 cells, and proliferation was reduced by more than 40% when endogenous VEGFR-3 was downregulated in BT474 cells. VEGFR-3 overexpression promoted a three-fold increase in motility and invasion and both motility and invasion were inhibited by downregulation of VEGFR-3. Furthermore, VEGFR-3 overexpression promoted cellular survival under stress conditions induced by staurosporine treatment and led to anchorage-independent growth. VEGFR-3 overexpression dramatically increased tumor formation in both hormone-dependent and independent xenograft models. With estrogen stimulation, MCF7-VEGFR-3 xenografts were ten times larger than control xenografts. Finally, downregulation of VEGFR-3 expression in both xenograft model cell lines led to a significant reduction of tumor growth. For the first time, we have demonstrated that VEGFR-3 overexpression promotes breast cancer cell proliferation, motility, survival, anchorage-independent growth and tumorogenicity in the absence of ligand expression.
登录
查看更多内容
影响因子:
82.9
作者:
Skobe, M;Hawighorst, T;Detmar, M
通讯作者:
Detmar, M
影响因子:
2.5
作者:
Kawakami, M;Yanai, Y;Hirata, K
通讯作者:
Hirata, K
影响因子:
6.4
作者:
Mattila, MMT;Ruohola, JK;Härkönen, PL
通讯作者:
Härkönen, PL
影响因子:
5.3
作者:
Ishii, H;Yazawa, T;Kitamura, H
通讯作者:
Kitamura, H
影响因子:
11.2
作者:
Lin, JM;Lalani, AS;Jooss, K
通讯作者:
Jooss, K